Report Detail
Global (United States, European Union and China) Biosimilar Market Research Report 2019-2025
- RnM3669386 |
- 14 August, 2019 |
- Global |
- 117 Pages |
- QYResearch |
- Pharma & Healthcare
A product is termed as biosimilar product, if it is a biological product with similar characteristics as that of a reference biological product, which possesses approval from agencies such as FDA. There would not be any major clinical difference in effectiveness and safety as that of reference product. Biosimilar products are made of complex molecules with high molecular weight produced through genetic engineering in living cells. Biologics drugs are costlier than respective chemical drugs. Biosimilar drugs can save around 30 to 40 % in terms of price relative to the respective biologics drugs. Biosimilars are useful for the treatment of illnesses such as anemia, autoimmune diseases, cancer, diabetes, growth hormone deficiencies, hematological diseases, kidney failure, rheumatoid arthritis and others. For the manufacturing of biosimilars, manufacturers have to develop environments that are ideal for the living cells, which remain sensitive to environmental conditions. Moreover, they need to develop distinctive process to entice the living cells for producing similar outcome to a prevalent biological treatment. The substitution of biological drugs with biosimilar drugs can save lot of money for public health care sector and patients. The regulatory authorities in developed nations are promoting biosimilar products.
In 2019, the market size of Biosimilar is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of 25.0% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Biosimilar.
This report studies the global market size of Biosimilar, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Biosimilar sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Allergan plc
BIOCAD
Biocon
BioXpress Therapeutics
Boehringer Ingelheim
Celltrion
Coherus BioSciences
Dr. Reddy’s Laboratories
Genor BioPharma
Intas Pharmaceuticals Limited
Novartis
Pfizer
Reliance Life Sciences
Market Segment by Product Type
Human Growth Hormones
Monoclonal Antibodies
Insulin
Peptides
Erythropoietin
Others
Market Segment by Application
Oncology
Chronic and Autoimmune Diseases
Growth Hormone Deficiency
Infectious Diseases
Others
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Biosimilar status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Biosimilar manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Biosimilar are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Biosimilar Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Human Growth Hormones
- 1.3.3 Monoclonal Antibodies
- 1.3.4 Insulin
- 1.3.5 Peptides
- 1.3.6 Erythropoietin
- 1.3.7 Others
- 1.4 Market Segment by Application
- 1.4.1 Global Biosimilar Market Share by Application (2019-2025)
- 1.4.2 Oncology
- 1.4.3 Chronic and Autoimmune Diseases
- 1.4.4 Growth Hormone Deficiency
- 1.4.5 Infectious Diseases
- 1.4.6 Others
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Biosimilar Market Size
- 2.1.1 Global Biosimilar Revenue 2014-2025
- 2.1.2 Global Biosimilar Sales 2014-2025
- 2.2 Biosimilar Growth Rate by Regions
- 2.2.1 Global Biosimilar Sales by Regions 2014-2019
- 2.2.2 Global Biosimilar Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Biosimilar Sales by Manufacturers
- 3.1.1 Biosimilar Sales by Manufacturers 2014-2019
- 3.1.2 Biosimilar Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Biosimilar Revenue by Manufacturers (2014-2019)
- 3.2.2 Biosimilar Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Biosimilar Market Concentration Ratio (CR5 and HHI)
- 3.3 Biosimilar Price by Manufacturers
- 3.4 Key Manufacturers Biosimilar Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Biosimilar Market
- 3.6 Key Manufacturers Biosimilar Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Human Growth Hormones Sales and Revenue (2014-2019)
- 4.1.2 Monoclonal Antibodies Sales and Revenue (2014-2019)
- 4.1.3 Insulin Sales and Revenue (2014-2019)
- 4.1.4 Peptides Sales and Revenue (2014-2019)
- 4.1.5 Erythropoietin Sales and Revenue (2014-2019)
- 4.1.6 Others Sales and Revenue (2014-2019)
- 4.2 Global Biosimilar Sales Market Share by Type
- 4.3 Global Biosimilar Revenue Market Share by Type
- 4.4 Biosimilar Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Biosimilar Sales by Application
6 United States
- 6.1 United States Biosimilar Breakdown Data by Company
- 6.2 United States Biosimilar Breakdown Data by Type
- 6.3 United States Biosimilar Breakdown Data by Application
7 European Union
- 7.1 European Union Biosimilar Breakdown Data by Company
- 7.2 European Union Biosimilar Breakdown Data by Type
- 7.3 European Union Biosimilar Breakdown Data by Application
8 China
- 8.1 China Biosimilar Breakdown Data by Company
- 8.2 China Biosimilar Breakdown Data by Type
- 8.3 China Biosimilar Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Biosimilar Breakdown Data by Company
- 9.2 Rest of World Biosimilar Breakdown Data by Type
- 9.3 Rest of World Biosimilar Breakdown Data by Application
- 9.4 Rest of World Biosimilar Breakdown Data by Countries
- 9.4.1 Rest of World Biosimilar Sales by Countries
- 9.4.2 Rest of World Biosimilar Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Allergan plc
- 10.1.1 Allergan plc Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Biosimilar
- 10.1.4 Biosimilar Product Introduction
- 10.1.5 Allergan plc Recent Development
- 10.2 BIOCAD
- 10.2.1 BIOCAD Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Biosimilar
- 10.2.4 Biosimilar Product Introduction
- 10.2.5 BIOCAD Recent Development
- 10.3 Biocon
- 10.3.1 Biocon Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Biosimilar
- 10.3.4 Biosimilar Product Introduction
- 10.3.5 Biocon Recent Development
- 10.4 BioXpress Therapeutics
- 10.4.1 BioXpress Therapeutics Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Biosimilar
- 10.4.4 Biosimilar Product Introduction
- 10.4.5 BioXpress Therapeutics Recent Development
- 10.5 Boehringer Ingelheim
- 10.5.1 Boehringer Ingelheim Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Biosimilar
- 10.5.4 Biosimilar Product Introduction
- 10.5.5 Boehringer Ingelheim Recent Development
- 10.6 Celltrion
- 10.6.1 Celltrion Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Biosimilar
- 10.6.4 Biosimilar Product Introduction
- 10.6.5 Celltrion Recent Development
- 10.7 Coherus BioSciences
- 10.7.1 Coherus BioSciences Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Biosimilar
- 10.7.4 Biosimilar Product Introduction
- 10.7.5 Coherus BioSciences Recent Development
- 10.8 Dr. Reddy’s Laboratories
- 10.8.1 Dr. Reddy’s Laboratories Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Biosimilar
- 10.8.4 Biosimilar Product Introduction
- 10.8.5 Dr. Reddy’s Laboratories Recent Development
- 10.9 Genor BioPharma
- 10.9.1 Genor BioPharma Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Biosimilar
- 10.9.4 Biosimilar Product Introduction
- 10.9.5 Genor BioPharma Recent Development
- 10.10 Intas Pharmaceuticals Limited
- 10.10.1 Intas Pharmaceuticals Limited Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Biosimilar
- 10.10.4 Biosimilar Product Introduction
- 10.10.5 Intas Pharmaceuticals Limited Recent Development
- 10.11 Novartis
- 10.12 Pfizer
- 10.13 Reliance Life Sciences
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Biosimilar Sales Channels
- 11.2.2 Biosimilar Distributors
- 11.3 Biosimilar Customers
12 Market Forecast
- 12.1 Global Biosimilar Sales and Revenue Forecast 2019-2025
- 12.2 Global Biosimilar Sales Forecast by Type
- 12.3 Global Biosimilar Sales Forecast by Application
- 12.4 Biosimilar Forecast by Regions
- 12.4.1 Global Biosimilar Sales Forecast by Regions 2019-2025
- 12.4.2 Global Biosimilar Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Biosimilar. Industry analysis & Market Report on Biosimilar is a syndicated market report, published as Global (United States, European Union and China) Biosimilar Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Biosimilar market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
